Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 856 AL 870

Cross-sectional and longitudinal associations between probable rapid eye movement sleep behavior disorder and impulse control disorders in Parkinson's disease

Cao R, Chen X, Xing F, Xie C, Hu P, Wang K.

Eur J Neurol. 2020 May;27(5):757-763. doi: 10.1111/ene.14177. Epub 2020 Mar 16.

Quantitative Electroencephalography Characteristics for Parkinson's Disease: A Systematic Review

Shirahige L, Berenguer-Rocha M, Mendonça S, Rocha S, Rodrigues MC, Monte-Silva K.

J Parkinsons Dis. 2020;10(2):455-470. doi: 10.3233/JPD-191840.

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases

Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H.

Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27.

A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease

Ettcheto M, Busquets O, Espinosa-Jiménez T, Verdaguer E, Auladell C, Camins A.

Curr Pharm Des. 2020;26(12):1286-1299. doi: 10.2174/1381612826666200211121416.

[Austrian neurologists under the swastika: Julius Wagner-Jauregg-Walther Birkmayer-Franz Seitelberger]

Martin M, Fangerau H, Karenberg A.

Nervenarzt. 2020 Feb;91(Suppl 1):100-108. doi: 10.1007/s00115-019-00848-1.

Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding

Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G.

Eur J Neurol. 2020 May;27(5):779-786. doi: 10.1111/ene.14179. Epub 2020 Mar 13.

Role of Helicobacter pylori infection in the manifestation of old age-related diseases

Zendehdel A, Roham M.

Mol Genet Genomic Med. 2020 Apr;8(4):e1157. doi: 10.1002/mgg3.1157. Epub 2020 Feb 17.

Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs

Kulshreshtha D, Ganguly J, Jog M.

Expert Opin Emerg Drugs. 2020 Mar;25(1):37-47. doi: 10.1080/14728214.2020.1729120. Epub 2020 Feb 20.

Healthy Effects of Plant Polyphenols: Molecular Mechanisms

Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, Stefani M.

Int J Mol Sci. 2020 Feb 13;21(4):1250. doi: 10.3390/ijms21041250.

Group-based music intervention in Parkinson's disease - findings from a mixed-methods study

Pohl P, Wressle E, Lundin F, Enthoven P, Dizdar N.

Clin Rehabil. 2020 Apr;34(4):533-544. doi: 10.1177/0269215520907669. Epub 2020 Feb 19.

Combined deep brain stimulation and thalamotomy for tremor-dominant Parkinson's disease

Kojoh A, Enatsu R, Kitagawa M, Mikami T, Sasagawa A, Kuribara T, Hirano T, Arihara M, Mikuni N.

J Clin Neurosci. 2020 Apr;74:244-247. doi: 10.1016/j.jocn.2020.02.014. Epub 2020 Feb 15.

Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-STARTUP

McClurg D, Panicker J, Walker RW, Cunnington A, Deane KHO, Harari D, Elders A, Booth J, Hagen S, Mason H, Stratton S.

BMJ Open. 2020 Feb 17;10(2):e034887. doi: 10.1136/bmjopen-2019-034887.

Very Late-Onset Niemann Pick Type C Disease: Example of Progressive Supranuclear Palsy Look-Alike Disorder

Kresojević N, Mandić-Stojmenović G, Dobričić V, Petrović I, Brajković L, Stefanova E, Svetel M, Kostić V.

Mov Disord Clin Pract. 2020 Jan 22;7(2):211-214. doi: 10.1002/mdc3.12892. eCollection 2020 Feb.

The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review

Pitz V, Malek N, Tobias ES, Grosset KA, Gentleman S, Grosset DG.

Mov Disord Clin Pract. 2020 Jan 7;7(2):218-222. doi: 10.1002/mdc3.12885. eCollection 2020 Feb.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias